Oxadiazole Derivatives of Diclofenac as an Anti-proliferative Agent for B-cell Non-Hodgkin Lymphoma: An In vitro and In Silico Studies

CONCLUSION: The compound (II) can be a potential therapeutic candidate for B-cell non-Hodgkin lymphoma and deserves further development as a novel anti-lymphoma agent.PMID:38279758 | DOI:10.2174/0115734064290905231228110023

Source: Medicinal Chemistry - January 27, 2024 Category: Chemistry Authors: Shaista Qayyum Almas Jabeen Sajda Ashraf Faiza Seraj Khalid Mohammad Khan Rafat Ali Siddiqui None Zaheer Ul-Haq Source Type: research